Ectin Research appoints Steven Glazer as chief medical officer

Ectin Research welcomes Steven Glazer as CMO for the company. Steven has an impressive experience from both the healthcare and biotech industry with extensive knowledge of research and development, medical and regulatory affairs in Europe and the United States. Previous positions encompass: Medical Director Novo Nordisk, Senior Vice President BioInvent, CMO Hansa Medical and current positions: CMO RhoVac, CMO Idogen, Board Member Immunicum, and Partner Ventac Partners.